SPONSOR
Lixte Biotechnology Holdings, Inc.
Total Trials
1
Recruiting
1
Phases
Phase 1, Phase 2
Conditions studied: Myelodysplastic Syndromes
Lixte Biotechnology Holdings, Inc. is a clinical research sponsor with 1 registered studies on ClinicalTrials.gov, of which 1 are actively recruiting participants. Research covers conditions including Myelodysplastic Syndromes.
The trial portfolio spans Phase 1, Phase 2 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Lixte Biotechnology Holdings, Inc.
How many clinical trials has Lixte Biotechnology Holdings, Inc. sponsored?
ClinicalMetric currently tracks 1 clinical trials sponsored by Lixte Biotechnology Holdings, Inc., of which 1 are actively recruiting participants. These trials cover conditions including Myelodysplastic Syndromes. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Lixte Biotechnology Holdings, Inc. research focus on?
Lixte Biotechnology Holdings, Inc. clinical trials span Myelodysplastic Syndromes. The research pipeline includes Phase 1, Phase 2 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Lixte Biotechnology Holdings, Inc. clinical trial?
To participate in a Lixte Biotechnology Holdings, Inc. trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Lixte Biotechnology Holdings, Inc. trials with current recruitment status updated daily.
Clinical Trials by Lixte Biotechnology Holdings, Inc.
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: September 2026 · Data Methodology